Abstract
Purpose
The aim of this work was to describe the usefulness of a simple 201Tl single-photon emission computed tomography (SPECT) technique in the differential diagnosis between tumour recurrence and radionecrosis during the follow-up of patients treated for low-grade gliomas.
Methods
The study population comprised 84 patients treated for low-grade gliomas who showed suspicion of tumour recurrence during their follow-up. All patients were examined by neuro-anatomical imaging procedures (CT, MRI) and 201Tl-SPECT. 201Tl-SPECT images were assessed by visual analysis based only on the information on the prescription form and by estimation of the uptake index (ratio of mean counts in the lesion to those in the contralateral mirror area). Examiners were blinded to the results of other tests.
Results
Under these conditions, the neuro-anatomical procedures yielded 26.2% inconclusive reports, with a global diagnostic accuracy of 0.61, a sensitivity of 0.63 and a specificity of 0.59. The global diagnostic accuracy for 201Tl-SPECT was 0.83, with a sensitivity of 0.88 and a specificity of 0.76. Diagnostic pitfalls were observed in regions with physiological 201Tl uptake, i.e. the posterior cranial fossa, diencephalon, lateral ventricles and cavernous and longitudinal venous sinuses. An uptake index cut-off value of 1.25 showed a sensitivity of 0.90 and specificity of 0.80 for detection of tumour activity.
Conclusion
201Tl-SPECT has adequate diagnostic accuracy to be part of routine algorithms in the follow-up of patients with low-grade glioma suspected of tumour recurrence, as an alternative to neuro-anatomical procedures and not solely as a complementary test.
Similar content being viewed by others
References
De Angelis LM. Brain tumors. N Engl J Med 2001; 344:114–123.
Recht LD, Bernstein M. Low-grade gliomas. Neurol Clin 1995; 14:847–860.
Kleihues P, Cavenee WK, eds. Tumours of the nervous system. Pathology and genetics. Lyon: International Agency for Research on Cancer (IARC), 2000.
Ashby LS. Low-grade gliomas: when and how to treat. In: Perry MC, ed. American Society of Clinical Oncology. Educational Book. Alexandria (VA): ASCO; 2000:688–695.
Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single photon emission computed tomography. Semin Nucl Med 2003; 33:148–162.
Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990; 31:965–969.
Van Veelen Ml, Avezaat CJ, Kros JM, et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998; 64:581–587.
Soler C, Beachesne P, Maataougui K, et al. Technetium-99m sestamibi brain SPECT for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998; 25:1649–1657.
Sasaki M, Kuwabara Y, Yoshida T, et al. A comparative study of thallium-201 SPECT, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 1998; 25:1261–1269.
Rubinstein R, Karger H, Pietrzyk U, et al. Use of201thallium brain SPECT, imaging registration, and semi-quantitative analysis in the follow-up of brain tumors. Eur J Radiol 1996; 21:188–195.
Ricci PE. Imaging of adult brain tumors. Neuroimagin Clin North Am 1999; 9:651–669.
Nelson SJ. Imaging of brain tumors after therapy. Neuroimagin Clin North Am 1999; 9:801–819.
Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MRI for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol 2000; 21:901–909.
Black KL, Hawkins RA, Kim KT, et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71:342–346.
Dierckx RA, Martin JJ, Dobbeleir A, et al. Sensitivity and specificity of thallium-201 SPECT in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21:621–633.
Isibashi M, Taguchi A, Sugita Y, et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995; 36:2201–2206.
Källén K, Heiling A-M, Brun A, et al. Preoperative grading of glioma malignancy with thallium-201 SPECT: comparison with conventional CT. Am J Neuroradiol 1996; 17:925–932.
Da Sun, Liu Q, Liu W, et al. Clinical applications of201Tl-SPECT imaging of brain tumors. J Nucl Med 2000; 41:5–10.
Kline JL, Noto RN, Glantz M. SPECT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. Am J Neuroradiol 1996; 17:1681–1686.
Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-FDG metabolism in glioma. J Nucl Med 1996; 37:457–462.
Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34:2085–2089.
Moustafa HM, Omar WM, Ezzat I, et al.201Tl SPECT in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 1994; 15:140–143.
Staffen W, Hondl N, Trinka E, et al. Clinical relevance of201Tl-chloride SPECT in the differential diagnosis of brain tumours. Nucl Med Commun 1998; 19:335–340.
Stokkel M, Stevens H, Taphoorn M, et al. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of201Tl-SPECT versus 18F-FDG PET using a dual-headed coincidence camera—a pilot study. Nucl Med Commun 1999; 20:411–417.
Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain imaging: a comparative study with pathological correlation. J Nucl Med 1987; 28:47–52.
Sehweil AM, McKillop JH, Milroy R, et al. Mechanism of Tl-201 uptake in tumours. Eur J Nucl Med 1989; 15:376–379.
Cicciarello R, d’Avella D, Gagliardi ME, et al. Time-related ultrastructural changes in an experimental model of whole brain irradiation. Neurosurgery 1996; 38:772–780.
Brismar T, Collins VP, Kesselberg M. Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 1989; 500:30–36.
Gomez-Río M, Martínez del Valle MD, Rodríguez-Fernández A, et al. Radionecrosis vs tumoral recurrence in brain tumors: diagnosis using Tl-201·SPECT [abstract]. Eur J Nucl Med 1998; 25:922.
Martínez del Valle MD, Gómez-Río M, Rodríguez-Fernández A, et al. Usefulness of Tl-201 SPECT in the diagnosis of radionecrosis versus tumoral recurrence in low grade glial tumours [abstract]. Eur J Nucl Med 2002; 29 [Suppl 1]: S229.
Sabbah P, Foehrenbach H, Dutertre G, et al. Multimodal anatomic, functional and metabolic brain imaging for tumor resection. J Clin Imaging 2002; 26:6–12.
Acknowledgement
The authors are grateful to Richard Davis for assistance with the English version of this text.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gómez-Río, M., Martínez del Valle Torres, D., Rodríguez-Fernández, A. et al. 201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis. Eur J Nucl Med Mol Imaging 31, 1237–1243 (2004). https://doi.org/10.1007/s00259-004-1501-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-004-1501-5